Societal CDMO (SCTL) Stock Analysis

What Societal CDMO does

Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets. Key offerings include drug development expertise, end-to-end regulatory guidance, clinical and commercial scale production, sterile fill/finish operations, freeze-drying (lyophilization), and integrated packaging and logistics solutions.

Key metrics

ETFs linked to SCTL

Broad-market and Healthcare sector ETFs an investor holding Societal CDMO is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SCTL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Societal CDMO?

Societal CDMO trades under the ticker SCTL on NASDAQ.

Which exchange is SCTL listed on?

SCTL is listed on NASDAQ.

What sector does Societal CDMO operate in?

Societal CDMO is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze SCTL in a portfolio?

PortView shows SCTL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.